FDA Investigator Mark R Mcclain
Mark R Mcclain has conducted inspections on 144 sites in 13 countries as of 13 Mar 2012. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
144
Last Inspection Date:
13 Mar 2012
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Ireland,
Japan,
Germany,
Sweden,
New Zealand,
France,
India,
China,
Canada,
Denmark,
Singapore,
Poland
FDA Investigators that have inspected at least one site in common with Mark R Mcclain:
Abby E Pelletier,
Adetutu M Gidado,
Alberto A Viciedo,
Alexander V Gontcharov,
Alice C Silva,
Alice S Tsao,
Alicia M Mozzachio,
Allison A Aldridge, PhD,
Alysia M Salonia,
Amanda E Lewin, PhD,
Amber G Wardwell,
Amy C Jordan,
Amy N Chen,
Anastasia M Shields,
Andrew M Barlow,
Anissa M Vargas,
Ann Marie Montemurro,
Anna Lazar,
Anne E Carpenter,
Anthony C Warchut,
Anthony N Onianwa,
Arsen Karapetyan,
Ashar P Parikh,
Asia D Clark,
Aurora Miha Trifanov,
Azza Talaat,
Barbara D Wright,
Barbara J Rincon,
Bernice F Hirsch,
Bijoy Panicker,
Blake C Hamann,
Bo Chi, PhD,
Bogdan Kurtyka,
Bradley D Newsad,
Brandy N Lepage,
Brenda P King,
Brenda W Uratani, PhD,
Brenna L Macdowell,
Bruce H Mccullough,
Burnell M Henry,
Byungja E Marciante,
Calvin B Koerner,
Camerson E Moore,
Carl A Huffman, III,
Carla A Norris,
Carla J Lundi,
Carlos Chavez,
Catherine J Laufmann,
Charanjeet Jassal,
Charisse K Green,
Charles I Ann,
Charles R Cote, RIC,
Christian D Lynch (CDL),
Christine H Lee,
Christine L Williams,
Christine M Whitby, CSO,
Christopher J Cruciotti,
Christopher Janik,
Chunsheng Cai, PhD,
Concepcion Cruz, Jr,
Constance Desimone,
Constantin Y Philopoulos,
Courtney N Long,
Cynthia F Kleppinger, MD,
Darin S Wiegers,
Daryl A Dewoskin,
Deborah A Greco,
Demitria J Xiradakis,
Dennis Cantellops Paite,
Diane C Thibodeau,
Diane L Raccasi,
Diane M Prince,
Dien N Nguyen,
Dominic R Frasca,
Donald C Obenhuber, PhD,
Dorota Matecka, PhD,
Dorothy P Kramer,
Douglas A Campbell,
Dr. Robert C Horan, MD,
Dr. Zhihao Qiu (Peter), PhD,
Edmund F Mrak, Jr,
Eduardo L Rodriguez,
Edward J Janik,
Eileen A Liu,
Elizabeth B Griffin,
Elizabeth M Jacobson,
Emily J Orban,
Emily J Schramm,
Eric C Schmitt,
Erin I Keith,
Evelyn Taha,
Felix Maldonado,
Frederick F Razzaghi,
Gabrielle J Swain,
Gale E Ryan,
George M Ibrahim,
George T Allen, Jr,
Gerard D Difiore,
Gwyn G Dickinson,
Hang N Guo,
Heika R Tait,
Helen B Ricalde,
Intkhab H Wahla,
Israel Santiago, OCM,
Jacek Cieslak, PhD,
Jacqueline Mdiaz Albertini,
James A Jagon,
James P Stumpff,
Janete F Guardia,
Jason A Rossi,
Jason F Chancey,
Jawaid Hamid,
Jeffery A Hangartner,
Jeffrey A Sommers,
Jeffrey J Thibodeau,
Joan A Loreng,
Joanne E King,
Joey V Quitania,
John A Gonzalez,
John A Hollings,
John J Thibodeau,
John P Mistler,
John P Shelton,
Jonah S Ufferfilge,
Jonathan G Matrisciano,
Jose Acruz Gonzalez,
José E Meléndez,
Jose Ohernandez Guzman,
Jose R Hernandez,
Jose R Lopez,
Joyce A Kellett,
Julie D Bringger,
Junho Pak,
Justin A Boyd,
Karen A Briggs,
Karen M Cooper,
Katherine Szestypalow,
Kathleen E Mcafoose,
Kenneth H Williams,
Kenneth Nieves,
Kent A Conforti,
Kevin P Foley,
Kham Phommachanh,
Kim Lthomas Cruse,
Kimberly M White,
Kristina J Donohue,
Kristy A Zielny,
Larry K Austin,
Lata C Mathew, PhD,
Laurie B Frazier,
Lawrence J Stringer,
LCDR Debra Emerson,
LCDR Michael H Tollon,
Lei Zhang, PhD,
Leiyun Boone, PhD,
Li Hongpaul Yeh, PhD,
Liming Zhang,
Linda F Murphy,
Linda L Green,
Lirissia Mccoy,
Lisa M Bellows,
Lisa R Hilliar,
Lixia Cai,
Lori M Newman,
Lorie S Hannappel,
Lucas B Leake,
Marcus F Yambot,
Margaret E Walsh,
Margaret M Annes,
Margaret M Sands,
Maria Joselopez Barragan, PhD,
Marianela Aponte Cruz,
Marie F Morin,
Martin J Guardia,
Mary Jeanet Mcgarry,
Maryam Tabatabaie,
Matthew B Casale,
Matthew C Watson,
Matthew D Silverman,
Maura Rooney,
Maya M Davis,
Mecado,
Megan A Haggerty,
Meisha A Mandal,
Meisha R Sampson,
Meisha Waters,
Miah Jung,
Michael A Charles,
Michael G Mayfield,
Michael P Sheehan,
Michael R Goga,
Michael Shanks, MS,
Michele L Obert,
Michelle M Noe Varga,
Michelle Yclark Stuart,
Miguel A Martinez Perez,
Mihaly S Ligmond,
Mikayla K Deardorff,
Mra Mcculloughj,
Mra Munizn,
Nabil Nakhoul,
Nancy G Schmidt,
Nancy L Rolli,
Nealie C Newberger,
Nicholas A Violand,
Nicholas F Lyons,
Nicholas L Paulin,
Nina Yang,
Omotunde O Osunsanmi,
Pal S Mayasandra,
Pamela N Agaba,
Paraluman S Leonin,
Parul M Patel,
Paul A Bonneau,
Paul E Stein,
Paul L Bellamy,
Paula A Trost,
Peter R Lenahan,
Philip F Istafanos, DMV, MS,
Philip Kreiter,
Prabhu P Raju,
Qin Xu,
Ramon E Martinez,
Rapti D Madurawe,
Raymond T Oji,
Rebecca B Welch,
Rebecca Rodriguez,
Regina T Brown,
Reginald D Neal,
Reyes Candau Chacon, PhD,
Richard H Penta,
Richard Ledwidge (nmi), PhD,
Robert D Tollefsen,
Robert J Ham,
Robert J Martin,
Robert Jennings,
Robert L Stevenson,
Robert O'brian,
Roger F Zabinski,
Rose Ashley,
Rumany C Penn, PharmD,
Russell J Glapion,
Russell K Riley,
Samir C Gala,
Samuel T Walker,
Sandra A Boyd,
Sandra A Hughes,
Sangeeta M Khurana, PhD,
Santos E Camara,
Sarah M Meng,
Sarah M Napier,
Sean R Marcsisin,
Sharon K Gershon,
Sharon K Thoma, PharmD,
Sherry G Bous,
Shirley J Berryman,
Sidney B Priesmeyer,
Simone E Pitts,
Stacey S Degarmo,
Stephanie Mangigian, MS/OSH, RN,
Stephen C Smith,
Stephen D Brown,
Stephen J Mottola,
Stephen R Souza,
Steven D Kehoe,
Steven Fong, MS, PhD,
Steven M Weinman,
Susan F Laska, MS,
Susan M Jackson,
Susan T Hadman,
Susanne M Richardson, MS RAC,
Suzanne M Healy,
Taichun Qin, PhD,
Tajah L Blackburn,
Tamil Arasu, PhD,
Tanya R Syffrard,
Temar Q Williams,
Thomas J Arista,
Thomas Siebertz,
Todd D Alspach,
Tomika L Crafter,
Tracey L Harris,
Troy R Petrillo,
Truong Xuan Nguyen (Andy),
Tyanna N Hadley,
Victoria M Daddeo,
Viviana Matta,
Walden H Lee,
Wayne E Seifert,
William Hallett, PhD,
William J Leonard,
Xiaohui Shen,
Xiaojun Yan,
Xikui Chen (nmi), PhD,
Yetao Jin, PhD,
Yiying E Chen,
Yumi J Hiramine,
Yvins Dezan,
Yvonne E Lozano,
Ziyang Su, PhD
Mark R Mcclain's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2004 | FDA 483 | Ecometics, Inc. - Form 483, 2004-08-02 |
December, 2003 | EIR | Eli Lilly And Company - EIR, 2003-12-16 |
September, 2006 | FDA 483 | CooperSurgical, Inc. - Form 483, 2006-11-06 |
August, 2006 | FDA 483 | Phoenix Divina Products Llc - Form 483, 2006-08-15 |
December, 2007 | FDA 483 | Alexion Pharmaceuticals, Inc. - Form 483, 2007-12-19 |
May, 2008 | FDA 483 | Sheffield Pharmaceuticals LLC - Form 483, 2008-05-15 |
December, 2011 | FDA 483 | Serumwerk Bernburg AG - Form 483, 2011-12-01 |
December, 2009 | FDA 483 | Mannkind Corporation - Form 483, 2009-12-04 |
December, 2008 | EIR | Charles River Laboratories Ireland Ltd. - EIR, 2014-05-08 |
April, 2010 | FDA 483 | RHG & Company Inc. - Form 483, 2010-04-23 |
June, 2006 | FDA 483 | Computerx Phamacy, Inc. - Form 483, 2006-06-09 |
December, 2008 | FDA 483 | LEO Laboratories Ltd. - Form 483, 2008-12-08 |
January, 2003 | EIR | Pfizer Laboratories Div Pfizer Inc - EIR, 2003-01-23 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more